Printable version
The Global HIV Vaccine Enterprise (Enterprise) works to accelerate the development of a preventive HIV vaccine to help end the AIDS epidemic. It is a unique collaboration of the world’s leading HIV vaccine research, funding, policymaking, advocacy and stakeholder organizations committed to advancing HIV vaccine research and development through coordination, collaboration, knowledge sharing and ensuring adequate resources are available and used effectively.
A talented and committed Secretariat supports the Enterprise. It manages, conceptualizes and facilitates Enterprise-endorsed programs that will have positive impact the overall HIV vaccine effort.
There are no current openings at this time. For more information, please contact info@vaccineenterprise.org.
